share_log

Pfizer | 4: Statement of changes in beneficial ownership of securities-Officer BOURLA ALBERT

Pfizer | 4: Statement of changes in beneficial ownership of securities-Officer BOURLA ALBERT

輝瑞 | 4:持股變動聲明-高管 BOURLA ALBERT
美股sec公告 ·  07/01 13:18
Moomoo AI 已提取核心訊息
Pfizer Inc. (PFE) Chairman & CEO Albert Bourla executed a transaction on 06/28/2024. The specific details of the transaction, including the number of shares involved, the nature of the shares, the transaction price, and the total value of the shares, were not disclosed in the announcement. The report also did not provide information on the number of shares held by Bourla after the transaction. The transaction reflects the ongoing financial activities of Pfizer's top executives and may be of interest to investors monitoring insider actions within the company.
Pfizer Inc. (PFE) Chairman & CEO Albert Bourla executed a transaction on 06/28/2024. The specific details of the transaction, including the number of shares involved, the nature of the shares, the transaction price, and the total value of the shares, were not disclosed in the announcement. The report also did not provide information on the number of shares held by Bourla after the transaction. The transaction reflects the ongoing financial activities of Pfizer's top executives and may be of interest to investors monitoring insider actions within the company.
2024年06月28日,輝瑞公司(PFE)董事長兼首席執行官阿爾伯特·布拉完成了一項交易。該公告未披露交易涉及的股票數量、股票性質、交易價格及持股價值。此外,報告也沒有提供布拉交易後的持股數量信息。此交易反映了輝瑞公司高管的持續金融活動,對於監控公司內部人士的行動的投資者可能具有一定的興趣。
2024年06月28日,輝瑞公司(PFE)董事長兼首席執行官阿爾伯特·布拉完成了一項交易。該公告未披露交易涉及的股票數量、股票性質、交易價格及持股價值。此外,報告也沒有提供布拉交易後的持股數量信息。此交易反映了輝瑞公司高管的持續金融活動,對於監控公司內部人士的行動的投資者可能具有一定的興趣。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息